The structure of a polyQ–anti-polyQ complex reveals binding according to a linear lattice model

[1]  T. Creamer,et al.  Evidence for polyproline II helical structure in short polyglutamine tracts. , 2006, Journal of molecular biology.

[2]  David Eisenberg,et al.  Recent atomic models of amyloid fibril structure. , 2006, Current opinion in structural biology.

[3]  Andreas Vitalis,et al.  Characterizing the conformational ensemble of monomeric polyglutamine , 2005, Proteins.

[4]  S. Finkbeiner,et al.  Crystallization and diffraction properties of the Fab fragment of 3B5H10, an antibody specific for disease-causing polyglutamine stretches. , 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

[5]  Ronald Wetzel,et al.  Polyglutamine homopolymers having 8–45 residues form slablike β‐crystallite assemblies , 2005, Proteins.

[6]  Ronald Wetzel,et al.  Polyglutamine aggregation nucleation: Thermodynamics of a highly unfavorable protein folding reaction , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  David Eisenberg,et al.  Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure , 2005, Nature.

[8]  Dennis C Winkler,et al.  Filaments of the Ure2p prion protein have a cross-β core structure , 2005 .

[9]  Pawel Sikorski,et al.  New model for crystalline polyglutamine assemblies and their connection with amyloid fibrils. , 2005, Biomacromolecules.

[10]  Dennis C Winkler,et al.  Filaments of the Ure2p prion protein have a cross-beta core structure. , 2005, Journal of structural biology.

[11]  R. Wetzel,et al.  Inhibition of polyglutamine aggregate cytotoxicity by a structure‐based elongation inhibitor , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  R. Wetzel,et al.  Mutational analysis of the structural organization of polyglutamine aggregates , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Christopher A Ross,et al.  Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders , 2002, Neuron.

[14]  S. A. Ross,et al.  A linear lattice model for polyglutamine in CAG-expansion diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Ronald Wetzel,et al.  Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Dimitri Krainc,et al.  Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease , 2002, Science.

[17]  M. Perutz,et al.  Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J T Finch,et al.  Amyloid fibers are water-filled nanotubes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Housman,et al.  A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila , 2002, Nature Genetics.

[20]  He Li,et al.  Interaction of Huntington Disease Protein with Transcriptional Activator Sp1 , 2002, Molecular and Cellular Biology.

[21]  Annalisa Pastore,et al.  Solution structure of polyglutamine tracts in GST‐polyglutamine fusion proteins , 2002, FEBS letters.

[22]  P. Patterson,et al.  Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Creamer,et al.  Determinants of the polyproline II helix from modeling studies. , 2002, Advances in protein chemistry.

[24]  R. Mariuzza,et al.  Molecular recognition in antibody-antigen complexes. , 2002, Advances in protein chemistry.

[25]  A. Pastore,et al.  A structural approach to trinucleotide expansion diseases , 2001, Brain Research Bulletin.

[26]  P. Patterson,et al.  New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins , 2001, Brain Research Bulletin.

[27]  R. Wetzel,et al.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.

[28]  C. Ross,et al.  Isolation of a 40-kDa Huntingtin-associated Protein* , 2001, The Journal of Biological Chemistry.

[29]  A. Tobin,et al.  Huntington's disease: the challenge for cell biologists. , 2000, Trends in cell biology.

[30]  E. Wanker.  Protein Aggregation and Pathogenesis of Huntingtons Disease: Mechanisms and Correlations , 2000, Biological chemistry.

[31]  H. Lehrach,et al.  Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[33]  M. MacDonald,et al.  Mutant Huntingtin Forms in Vivo Complexes with Distinct Context-Dependent Conformations of the Polyglutamine Segment , 1999, Neurobiology of Disease.

[34]  M. MacDonald,et al.  Amyloid Formation by Mutant Huntingtin: Threshold, Progressivity and Recruitment of Normal Polyglutamine Proteins , 1998, Somatic cell and molecular genetics.

[35]  E. Hirsch,et al.  Heterogeneous Intracellular Localization and Expression of Ataxin-3 , 1998, Neurobiology of Disease.

[36]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[37]  L. Lally.  The CCP 4 Suite — Computer programs for protein crystallography , 1998 .

[38]  E. Altschuler,et al.  Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[39]  B. Katz.  Binding of biotin to streptavidin stabilizes intersubunit salt bridges between Asp61 and His87 at low pH. , 1997, Journal of molecular biology.

[40]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[41]  Y. Agid,et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.

[42]  R. Williams,et al.  Crystal structure of a diabody, a bivalent antibody fragment. , 1994, Structure.

[43]  H. Wolfson,et al.  Shape complementarity at protein–protein interfaces , 1994, Biopolymers.

[44]  P. Chambon,et al.  The N‐terminal domain of the human TATA‐binding protein plays a role in transcription from TATA‐containing RNA polymerase II and III promoters. , 1994, The EMBO journal.

[45]  M. Sternberg,et al.  Left-handed polyproline II helices commonly occur in globular proteins. , 1993, Journal of molecular biology.

[46]  D Altschuh,et al.  A conformation of cyclosporin A in aqueous environment revealed by the X-ray structure of a cyclosporin-Fab complex. , 1992, Science.

[47]  P. Cazenave,et al.  Mouse V lambda x gene sequence generates no junctional diversity and is conserved in mammalian species. , 1990, Journal of immunology.

[48]  P. V. von Hippel,et al.  DNA "melting" proteins. IV. Fluorescence measurements of binding parameters for bacteriophage T4 gene 32-protein to mono-, oligo-, and polynucleotides. , 1976, The Journal of biological chemistry.

[49]  P. V. von Hippel,et al.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. , 1974, Journal of molecular biology.